NCT06657508Active, not recruiting
Continuous Glucose Monitoring in People With Diabetes on Dialysis
Real-World Evaluation of Continuous Glucose Monitoring Data in People With Diabetes and End-Stage Renal Disease Receiving Dialysis
Source: ClinicalTrials.gov · Last updated 29 Apr 2026
Brief summary (registry, in English)
Continuous glucose monitoring is a sensor, which monitors glucose levels continuously throughout the day. In people with diabetes, especially those treated with insulin, this sensor helps guide the amount of treatment (such as insulin) required to maintain glucose within target. In dialysis, the glucose levels and insulin needs can change a lot because of the kidney failure and dialysis treatments. The goal of this observational study is to describe the changes in glucose during and in between dialysis sessions over two weeks by using continuous glucose monitoring. The study will also explore whether there is a relationship between the trend of the glucose and fluid level changes during and in between dialysis treatments. Also, the study will assess whether there is a relationship between glucose levels and several long-term outcomes, such as admissions to the hospital, for up to five years.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 23 Oct 2024
- Start date
- 31 Dec 2024
- Primary completion date
- 28 Oct 2025
- Lead sponsor
- University of Nottingham
- Diseases
- Chronic kidney disease
- NCT number
- NCT06657508
What you commit to
- Study type: Observational
- Planned participants: 40
- From 31 Dec 2024 to the primary completion date, 28 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Serious illness or events with life expectancy \< 3 months or other significant illness which, in the opinion of the study clinician, precludes involvement
Other
- Participation in other competing studies/clinical trials as determined by the study investigator
Who the study is looking for
- Age: ≥18 years (no upper age limit)
- People with insulin-treated diabetes who receive NHS funded continuous glucose monitoring as part of their routine clinical care
- Diabetes duration \> 6 months
- People with end-stage renal disease established on dialysis (maintenance haemodialysis or peritoneal dialysis)
- Ability to give informed consent
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospitals of Derby and Burton Coordinator of this site? Confirm its status | Derby | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.